Literature DB >> 21809033

Correlation between the expression of the BAG-1 gene and clinicopathologic factors in colorectal cancer.

Nian-Feng Sun1, Qing-Yi Meng, San-Yuan Hu, Ai-Ling Tian, Rui-Hua Wang, Zhao-Xuan Liu, Li Xu.   

Abstract

OBJECTIVE: The present study aims to investigate the expression and significance of the anti-apoptotic gene Bag-1 in colorectal cancer and to evaluate the relationship between the gene and the disease.
METHODS: Bag-1 expression was examined in 320 colorectal cancer and 30 normal colorectal tissue samples using reverse transcriptase polymerase chain reaction (RT-PCR) and the immunohistochemical staining (streptavidin-biotin-peroxidase complex method.
RESULTS: Using RT-PCR, Bag-1 was observed to be expressed in colorectal cancer tissues, but not in normal colorectal tissues. The expression of Bag-1 in colorectal cancer was closely correlated with pathologic grade, distant metastasis, Dukes stage, and prognosis, but it was not correlated with the pathologic type, tumor diameter, depth of invasion, and lymph node metastasis.
CONCLUSION: Bag-1 protein was found to be overexpressed in colorectal cancer. They might be regarded as a biomarker for the diagnosis of the early stages of colorectal cancer. In addition, they have particular significance for the prognosis of colorectal cancer.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21809033     DOI: 10.1007/s00432-011-1011-3

Source DB:  PubMed          Journal:  J Cancer Res Clin Oncol        ISSN: 0171-5216            Impact factor:   4.553


  22 in total

1.  Bag-1 expression in thyroid neoplasm: its correlation with Bcl-2 expression and carcinoma dedifferentiation.

Authors:  Yasuhiro Ito; Hiroshi Yoshida; Keiichi Nakano; Yuuki Takamura; Akihiro Miya; Kaoru Kobayashi; Tamotsu Yokozawa; Fumio Matsuzuka; Nariaki Matsuura; Kennichi Kakudo; Kanji Kuma; Akira Miyauchi
Journal:  Anticancer Res       Date:  2003 Jan-Feb       Impact factor: 2.480

Review 2.  Molecular markers of prostate cancer outcome.

Authors:  David I Quinn; Susan M Henshall; Robert L Sutherland
Journal:  Eur J Cancer       Date:  2005-04       Impact factor: 9.162

Review 3.  BAG-1, an anti-apoptotic tumour marker.

Authors:  Shou-Ching Tang
Journal:  IUBMB Life       Date:  2002-02       Impact factor: 3.885

4.  Nuclear or cytoplasmic localization of Bag-1 distinctly correlates with pathologic behavior and outcome of gastric carcinomas.

Authors:  Hua-chuan Zheng; Xiao-yan Xu; Ya-nan Xing; Zheng-li Wei; Hiroyuki Takahashi; Shinji Masuda; Yasuo Takano
Journal:  Hum Pathol       Date:  2010-01-25       Impact factor: 3.466

5.  Expression of BAG-1 protein correlates with aggressive behavior of prostate cancers.

Authors:  Maryla Krajewska; Bruce C Turner; Ahmed Shabaik; Stan Krajewski; John C Reed
Journal:  Prostate       Date:  2006-06-01       Impact factor: 4.104

6.  Nuclear BAG-1 expression is a biomarker of poor prognosis in esophageal squamous cell carcinoma.

Authors:  T Noguchi; S Takeno; T Shibata; S Fumoto; Y Uchida; S Yokoyama; H-E Gabbert; W Müller
Journal:  Dis Esophagus       Date:  2003       Impact factor: 3.429

7.  Prolonged cell survival enhances peritoneal dissemination of gastric cancer cells.

Authors:  A Yawata; M Adachi; H Okuda; Y Naishiro; T Takamura; M Hareyama; S Takayama; J C Reed; K Imai
Journal:  Oncogene       Date:  1998-05       Impact factor: 9.867

8.  Expression and location of Hsp70/Hsc-binding anti-apoptotic protein BAG-1 and its variants in normal tissues and tumor cell lines.

Authors:  S Takayama; S Krajewski; M Krajewska; S Kitada; J M Zapata; K Kochel; D Knee; D Scudiero; G Tudor; G J Miller; T Miyashita; M Yamada; J C Reed
Journal:  Cancer Res       Date:  1998-07-15       Impact factor: 12.701

9.  Nuclear BAG-1 expression inhibits apoptosis in colorectal adenoma-derived epithelial cells.

Authors:  J D Barnes; N J Arhel; S S Lee; A Sharp; M Al-Okail; G Packham; A Hague; C Paraskeva; A C Williams
Journal:  Apoptosis       Date:  2005-03       Impact factor: 4.677

10.  Downregulated parafibromin expression is a promising marker for pathogenesis, invasion, metastasis and prognosis of gastric carcinomas.

Authors:  Hua-Chuan Zheng; Hiroyuki Takahashi; Xiao-Han Li; Takuo Hara; Shinji Masuda; Yi-Fu Guan; Yasuo Takano
Journal:  Virchows Arch       Date:  2007-12-14       Impact factor: 4.064

View more
  1 in total

1.  Silencing Bag-1 gene via magnetic gold nanoparticle-delivered siRNA plasmid for colorectal cancer therapy in vivo and in vitro.

Authors:  Wenbai Huang; Zhan'ao Liu; Guanzhou Zhou; Jianmin Ling; Ailing Tian; Nianfeng Sun
Journal:  Tumour Biol       Date:  2016-02-04
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.